<DOC>
	<DOCNO>NCT01622907</DOCNO>
	<brief_summary>Prospective , multi-center , investigator-driven trial . This study hypothesize combine surgical endoscopic transcatheter technique stag fashion provide superior clinical outcome isolate surgical/EP approach patient persistent AF last &gt; 1 year &gt; 5 year . The proposed procedure involve creation cardiac lesion epicardially apply radiofrequency ( RF ) ablation minimally invasive surgical ( MIS ) approach follow delayed EP ablation procedure perform 1-2 month surgical operation .</brief_summary>
	<brief_title>Hybrid Staged Operating Room Interventional Catheter Ablation Atrial Fibrillation</brief_title>
	<detailed_description>New ablative technology develop simplify original `` cut sew '' Cox Maze procedure use routine treatment AF patient undergo open-heart surgery , well stand-alone arrhythmia procedure . A minimally invasive , thoracoscopic surgical treatment AF able address trigger AF pulmonary vein isolation leave posterior atrial wall exclusion , pulmonary vein next important atrial substrate promotion AF . New hybrid procedure attempt combine success rate minimally invasive nature thoracoscopic mini-Maze effectiveness short recovery time associated catheter ablation . The key blocking signal cause arrhythmia outside ( epicardial ) inside ( endocardial ) heart . Suboptimal result catheter ablation surgery suggest success treatment long stand persistent AF persistent lone AF benefit close collaboration cardiothoracic surgeon electrophysiologist , offer patient best available combination treatment give set cardiovascular lesion . Hybrid treatment AF increasingly adopt Europe United States assess treatment AF Coordinating Center ( Brescia , Italy ) promising result .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Subjects treat initially thorocoscopic epicardial surgical RF ablation create box lesion around pulmonary vein , ganglionated plexi , superior vena cavainferior vena cava ( SVCIVC ) connect lesion . Four maximum 8 week follow surgical ablation procedure , patient return EP Laboratory : Assess integrity Box lesion Eliminate gap surgical lesion find Terminate fragment potential Perform CavalTricuspid Isthmus ( CTI ) lesion line Upon completion procedure , integrity lesion reassess prior withdraw EP catheter LA . History Recurrent Persistent Long Standing Persistent AF 5 year ; Documented leave atrial size ( AP diameter ) great 55 mm ; Documented leave ventricular ejection fraction ( LVEF ) 40 % less ; History cerebrovascular disease , include stroke transient ischemic attack ( TIA ) within 6 month prior enrollment ; Significant underlying structural heart disease require surgical procedural intervention ; Previous heart surgery ; Chronic obstructive pulmonary disease ( &lt; 70 % predictive lung function ) ; Contraindication anticoagulant therapy , inability comply anticoagulant therapy ; Other clinical condition preclude inclusion ( e.g. , organ disease , disturbances hemostasis , etc . ) ; Pregnancy , plan pregnancy breastfeeding ; Concomitant cardiac surgery procedure plan .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Catheter ablation , radiofrequency</keyword>
	<keyword>Epicardially apply radiofrequency ablation</keyword>
	<keyword>Minimally invasive surgical approach</keyword>
</DOC>